It seems at least plausible that the reductions in those miRNAs which bind to and require TDP-43 for their biogenesis in vitro[14,19] reflect an impaired TDP-43 function or altered subcellular TDP-43 distribution in ALS patients. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.